5 years ago

Two novel diterpenes from the roots of Phyllanthus acidus (L.) Skeel

Two novel diterpenes from the roots of Phyllanthus acidus (L.) Skeel
Two novel diterpenes, phyllanes A and B, were isolated from the roots of Phyllanthus acidus, along with the cleistanthane diterpene, spruceanol. Their chemical structures were unambiguously elucidated by extensive 1D and 2D NMR analyses and high resolution mass spectroscopic data, as well as by comparison with literature data. While phyllanes A and B are respectively reminiscent of amphilectane and serrulatane diterpenoids, their highly unusual substitution patterns and their co-occurrence with spruceanol led us to assume that they might correspond to an unprecedented type of re-arranged cleistanthane-diterpenoid precursors, resulting in final products that display a unique scaffold among terrestrial diterpenoids. Accordingly, a possible biosynthetic route to the two new compounds from the readily accessible spruceanol is proposed herein. These two compounds were evaluated for their cytotoxic activities against two cancer cell lines. Only phyllane B exerted a moderate activity against K562 and HepG2 cell line with IC50 values of 28.90 and 45.23 μg/mL, respectively.

Publisher URL: www.sciencedirect.com/science

DOI: S0040402017307457

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.